Allergy and Immunology · Maryville, TN
NPI
1033569439
Since 2016
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
616 W Lamar Alexander Pkwy
Maryville, TN, 37801
Phone (865) 273-0008
Groups this clinician bills Medicare through
Medicare paid, 2024
$233K
18,479 services
Medicare patients, 2024
887
Average age 73
Drug cost, 2024
$1.0M
1,659 prescriptions
Company payments, 2025
$261K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas C Kolinsky was code 95165 (treatment - miscellaneous), 8,230 times for 204 patients. In total Nicholas C Kolinsky billed 18,479 services in 47 codes, and Medicare paid $233K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 8,230 | 204 | $9.96 | $82K |
| 95004 Test - Miscellaneous | Office | 3,012 | 46 | $2.36 | $7,122 |
| 95117 Treatment - Miscellaneous | Office | 1,699 | 566 | $7.41 | $13K |
| J2357 Injection, omalizumab, 5 mg | Office | 945 | 11 | $30.01 | $28K |
| 95024 Test - Miscellaneous | Office | 709 | 41 | $5.28 | $3,746 |
| 95115 Treatment - Miscellaneous | Office | 407 | 104 | $6.69 | $2,723 |
| 99204 Office E&M - New | Office | 118 | 118 | $106.27 | $13K |
| 99214 Office E&M - Established | Office | 110 | 78 | $87.00 | $9,570 |
| 96372 Injection Administration | Office | 102 | 38 | $9.87 | $1,006 |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 72 | 24 | $0.04 | $2.75 |
| 94010 Pulmonary Function Testing | Office | 37 | 33 | $16.88 | $624 |
| 70486 CT/CTA - Head and Neck | Office | 28 | 28 | $63.88 | $1,789 |
| 94060 Pulmonary Function Testing | Office | 27 | 27 | $24.96 | $674 |
| 95012 Pulmonary | Office | 13 | 13 | $12.35 | $161 |
By year: 2022 $193K for 13,701 services; 2023 $252K for 16,854 services; 2024 $233K for 18,479 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas C Kolinsky prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 293 prescriptions and refills. In total Nicholas C Kolinsky wrote 1,659 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 293 | 366 | 85 | $231K |
| Fluticasone Propionate Generic | 120 | 195 | 59 | $1,796 |
| Azelastine Hcl Generic | 110 | 187 | 54 | $3,480 |
| Montelukast Sodium Generic | 91 | 181 | 47 | $607 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 89 | 102 | 51 | $1,934 |
| Omeprazole Generic | 86 | 181 | 35 | $1,351 |
| Ryaltris Olopatadine Hcl/Mometasone | 56 | 70 | 24 | $18K |
| Ipratropium Bromide Generic | 55 | 86 | 32 | $2,262 |
| Prednisone Generic | 51 | 51 | 49 | $111 |
| Xolair Omalizumab | 47 | 48 | Under 11 | $175K |
| Triamcinolone Acetonide Generic | 43 | 45 | 34 | $738 |
| Symbicort Budesonide/Formoterol Fumarate | 40 | 46 | 12 | $11K |
| Epinephrine Generic | 40 | 44 | 36 | $8,126 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 37 | 37 | 33 | $490 |
| Tezspire Tezepelumab-Ekko | 36 | 36 | Under 11 | $150K |
Brand drugs: 762 claims; generic drugs: 897 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas C Kolinsky $261K ($261K in general payments such as food, travel and fees) from 28 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $160K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 184 | $160K |
| Regeneron Healthcare Solutions, Inc. REGN | 40 | $33K |
| Ionis Pharmaceuticals, Inc. IONS | 25 | $19K |
| CSL Behring CSL.AX | 38 | $15K |
| GlaxoSmithKline, LLC. GSK | 29 | $15K |
| Grifols USA, LLC | 18 | $4,677 |
| Genzyme Corporation SNY | 15 | $4,649 |
| Blueprint Medicines Corporation SNY | 7 | $4,109 |
| Incyte Corporation INCY | 3 | $2,257 |
| Grifols Shared Services North America, Inc. | 1 | $1,328 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.